Gland Pharma Limited (GLAND) — Announcement
Gland Pharma announced a schedule of analyst and institutional investor meetings, including a one-on-one session with SiMPL PMS on June 22, 2026, arranged by Kotak Securities. The notice emphasizes that the schedule may change due to operational exigencies and serves as an informational update for stakeholders. This event provides investors with direct engagement opportunities with company management ahead of potential market-moving discussions.
About Gland Pharma Limited (GLAND)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when GLAND files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GLAND — Free💡 Ask AI about this filing
📊 More GLAND filings
- Financial Results — 26 June 2026 Gland Pharma announced that its trading window will close on June 27, 2026, ahead of the unaudited q...
- Announcement — 22 June 2026 Gland Pharma announced its schedule for upcoming analyst and institutional investor meetings, includ...
- 🟡 Voting Results — 18 June 2026 Gland Pharma Limited's shareholders approved the reappointment of Udo Jahannes Vetter as Independent...
- 🟡 Board Meeting — 16 June 2026 Gland Pharma disclosed that independent director Satyanarayana Murthy Chavali resigned effective Jun...
- Announcement — 16 June 2026 Gland Pharma announced its upcoming analyst and institutional investor meeting schedule, listing one...
🔥 Also filed on 17 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when GLAND files new disclosures
Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GLAND — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research